Artwork

Sisällön tarjoaa Perplexity. Perplexity tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Player FM - Podcast-sovellus
Siirry offline-tilaan Player FM avulla!

Meta's Orion AR Glasses, OpenAI's For-Profit Pivot, and New Blood Type Discovered

6:07
 
Jaa
 

Manage episode 442182356 series 3554250
Sisällön tarjoaa Perplexity. Perplexity tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.

What would you like to see more of? Let us know!

In this episode of Discover Daily, we begin with Meta's Orion AR glasses prototype, which uses silicon carbide lenses and a neural wristband for intuitive control. These lightweight glasses project holograms onto the real world, offering a 70-degree field of view and gesture controls. While still in development, Orion represents a significant step towards Meta's vision of AR as the future of personal computing.
We also delve into OpenAI's controversial shift from a nonprofit to a for-profit model, potentially valuing the company at $150 billion. This move has sparked debates about AI ethics and development priorities, with critics like Elon Musk calling it "illegal." The restructuring aims to attract investors and compete with tech giants, but raises questions about OpenAI's commitment to its original mission of developing beneficial AI.
Our deep dive focuses on the discovery of the MAL blood group system, solving a 50-year mystery in hematology. This rare blood type, characterized by the absence of the AnWj antigen, has significant implications for transfusion medicine and patient care. The discovery opens new avenues for research in genetic screening, antigen development, and personalized medicine, potentially leading to improved transfusion safety and novel therapeutic approaches.
From Perplexity's Discover Feed:
https://www.perplexity.ai/page/meta-s-orion-ar-glasses-PgiV4ahWRR2FUrtReWqGZQ
https://www.perplexity.ai/page/openai-s-for-profit-pivot-Mg7ldRffSXme1JG83ig7lQ
https://www.perplexity.ai/page/new-blood-group-identified-LEhLeJENRHSrdAPRtKwUjA

Perplexity is the fastest and most powerful way to search the web. Perplexity crawls the web and curates the most relevant and up-to-date sources (from academic papers to Reddit threads) to create the perfect response to any question or topic you’re interested in.
Take the world's knowledge with you anywhere. Available on iOS and Android
Join our growing Discord community for the latest updates and exclusive content.
Follow us on:

  continue reading

213 jaksoa

Artwork
iconJaa
 
Manage episode 442182356 series 3554250
Sisällön tarjoaa Perplexity. Perplexity tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.

What would you like to see more of? Let us know!

In this episode of Discover Daily, we begin with Meta's Orion AR glasses prototype, which uses silicon carbide lenses and a neural wristband for intuitive control. These lightweight glasses project holograms onto the real world, offering a 70-degree field of view and gesture controls. While still in development, Orion represents a significant step towards Meta's vision of AR as the future of personal computing.
We also delve into OpenAI's controversial shift from a nonprofit to a for-profit model, potentially valuing the company at $150 billion. This move has sparked debates about AI ethics and development priorities, with critics like Elon Musk calling it "illegal." The restructuring aims to attract investors and compete with tech giants, but raises questions about OpenAI's commitment to its original mission of developing beneficial AI.
Our deep dive focuses on the discovery of the MAL blood group system, solving a 50-year mystery in hematology. This rare blood type, characterized by the absence of the AnWj antigen, has significant implications for transfusion medicine and patient care. The discovery opens new avenues for research in genetic screening, antigen development, and personalized medicine, potentially leading to improved transfusion safety and novel therapeutic approaches.
From Perplexity's Discover Feed:
https://www.perplexity.ai/page/meta-s-orion-ar-glasses-PgiV4ahWRR2FUrtReWqGZQ
https://www.perplexity.ai/page/openai-s-for-profit-pivot-Mg7ldRffSXme1JG83ig7lQ
https://www.perplexity.ai/page/new-blood-group-identified-LEhLeJENRHSrdAPRtKwUjA

Perplexity is the fastest and most powerful way to search the web. Perplexity crawls the web and curates the most relevant and up-to-date sources (from academic papers to Reddit threads) to create the perfect response to any question or topic you’re interested in.
Take the world's knowledge with you anywhere. Available on iOS and Android
Join our growing Discord community for the latest updates and exclusive content.
Follow us on:

  continue reading

213 jaksoa

Все серии

×
 
Loading …

Tervetuloa Player FM:n!

Player FM skannaa verkkoa löytääkseen korkealaatuisia podcasteja, joista voit nauttia juuri nyt. Se on paras podcast-sovellus ja toimii Androidilla, iPhonela, ja verkossa. Rekisteröidy sykronoidaksesi tilaukset laitteiden välillä.

 

Pikakäyttöopas